Ludovico De Stefano

Pavia, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 54 publications

Real-world therapeutic strategies in active adult-onset Still's disease: clinical insights from the GIRRCS-AOSD study group.

Real-world therapeutic strategies in active adult-onset Still's disease: clinical insights from the GIRRCS-AOSD study group.

Journal: Frontiers in immunology

Published: April 10, 2026

Association between canakinumab dose and long-term remission in Still's disease: insights from the AIDA network registry.

Association between canakinumab dose and long-term remission in Still's disease: insights from the AIDA network registry.

Journal: Frontiers in pharmacology

Published: April 03, 2026

Long-term remission and monocyclic course in Still's disease patients starting canakinumab early: data from the international AIDA network registry.

Long-term remission and monocyclic course in Still's disease patients starting canakinumab early: data from the international AIDA network registry.

Journal: Seminars in arthritis and rheumatism

Published: February 24, 2026

Application of machine learning techniques to explore the occurrence of macrophage activation syndrome in Still's disease: results from the GIRRCS AOSD Study Group and the AIDA Network Still's Disease Registry.

Application of machine learning techniques to explore the occurrence of macrophage activation syndrome in Still's disease: results from the GIRRCS AOSD Study Group and the AIDA Network Still's Disease Registry.

Journal: Frontiers in immunology

Published: February 14, 2026

Assessment of myositis specific antibodies in primary chronic arthritis: single centre prospective study.

Assessment of myositis specific antibodies in primary chronic arthritis: single centre prospective study.

Journal: Clinical and experimental rheumatology

Published: May 18, 2025

From image to insight: leveraging imaging to empower patients with inflammatory arthropathies.

From image to insight: leveraging imaging to empower patients with inflammatory arthropathies.

Journal: Frontiers in medicine

Published: May 16, 2025

Unfolding dermatological spectrum of Still's disease: a cohort study from the International AIDA Network Still's Disease Registry.

Unfolding dermatological spectrum of Still's disease: a cohort study from the International AIDA Network Still's Disease Registry.

Journal: Rheumatology (Oxford, England)

Published: March 03, 2025

Prediction of long-term drug-free outcomes in ACPA-positive and ACPA-negative rheumatoid arthritis by combined clinical and ultrasound assessment of residual disease: a 5-year prospective study.

Prediction of long-term drug-free outcomes in ACPA-positive and ACPA-negative rheumatoid arthritis by combined clinical and ultrasound assessment of residual disease: a 5-year prospective study.

Journal: RMD open

Published: October 02, 2024

Tender joints in early autoantibody-negative rheumatoid arthritis: Should they be included in the scoring of joint involvement of the 2010 ACR/EULAR classification criteria?

Tender joints in early autoantibody-negative rheumatoid arthritis: Should they be included in the scoring of joint involvement of the 2010 ACR/EULAR classification criteria?

Journal: Seminars in arthritis and rheumatism

Published: August 15, 2024

Timely escalation to second-line therapies after failure of methotrexate in patients with early rheumatoid arthritis does not reduce the risk of becoming difficult-to-treat.

Timely escalation to second-line therapies after failure of methotrexate in patients with early rheumatoid arthritis does not reduce the risk of becoming difficult-to-treat.

Journal: Arthritis research & therapy

Published: July 18, 2024

High serum levels of CXCL13 predict lower response to csDMARDs in both ACPA-positive and ACPA-negative early rheumatoid arthritis.

High serum levels of CXCL13 predict lower response to csDMARDs in both ACPA-positive and ACPA-negative early rheumatoid arthritis.

Journal: Rheumatology (Oxford, England)

Published: July 14, 2024

The Systemic Score May Identify Life-Threatening Evolution in Still Disease: Data from the GIRRCS AOSD-Study Group and the AIDA Network Still Disease Registry.

The Systemic Score May Identify Life-Threatening Evolution in Still Disease: Data from the GIRRCS AOSD-Study Group and the AIDA Network Still Disease Registry.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: November 01, 2023

Showing 1-12 of 54

Last Updated: 09/26/2026